Adaptation and implementation of health Qigong and Tai Chi exercises on quality of life and physical functioning in patients with atrial fibrillation: a feasibility study

ISRCTN ISRCTN16703816
DOI https://doi.org/10.1186/ISRCTN16703816
IRAS number 286914
Secondary identifying numbers IRAS 286914, CPMS 49781
Submission date
28/02/2022
Registration date
25/03/2022
Last edited
13/12/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Tai Chi and Qigong traditional Chinese exercises are thought to be beneficial in many health conditions including heart conditions, however, there is a lack of studies showing the effect of these exercises on patients with atrial fibrillation (AF; the most common irregular heart rhythm). Therefore, the aim of this research is: To assess the feasibility of a future randomised controlled trial of Tai Chi and Qigong for patients with atrial fibrillation in terms of patients’ acceptability and capability to continue the programme and their satisfaction with it, in addition to evaluating health-related quality of life and physical functioning.

Who can participate?
Approximately 106 adult participants with confirmed AF diagnoses will be recruited from primary care.

What does the study involve?
The study will take place online via the virtual platform (Zoom).
The exercise group will learn a Tai Chi and Qigong routine for 12 weeks, led by a qualified instructor. All the movements will be carried out according to the participants' capability. The participants in both groups may be interviewed online for process evaluation requirements; and 10 participants from the intervention group for the embedded qualitative study.

What are the possible benefits and risks of participating?
Benefits
This study provides an opportunity for participants to learn new exercise movements which may help to improve health and well-being. The exercises will be delivered in a group format (either in person or via video-link), and participants may find some benefit from meeting up with other people.
Risks
This study will provide specially designed exercise movements suitable for older adults, which are of low to moderate intensity. Unexpected serious adverse events may occur but most likely will not be research-related events. Participants may experience some muscle/joint ache after taking part, but this risk is low.

Where is the study run from?
University of Liverpool (UK)

When is the study starting and how long is it expected to run for?
March 2020 to December 2023

Who is funding the study?
The study is funded by the Libyan Embassy - Cultural Attache.

Who is the main contact?
Ms Ahlam Abu Elkhair, ahlam244@liverpool.ac.uk

Contact information

Ms Ahlam Abu Elkhair
Principal Investigator

William Henry Duncan Building
University of Liverpool
6 West Derby Street
Liverpool
L7 8TX
United Kingdom

ORCiD logoORCID ID 0000-0002-0086-6600
Phone +44 7424101981
Email ahlam244@liverpool.ac.uk
Ms Ahlam Abu Elkhair
Scientific

William Henry Duncan Building
University of Liverpool
6 West Derby Street
Liverpool
L7 8TX
United Kingdom

Phone +44 7424101981
Email ahlam244@liverpool.ac.uk
Ms Ahlam Abu Elkhair
Public

William Henry Duncan Building
University of Liverpool
6 West Derby Street
Liverpool
L7 8TX
United Kingdom

Phone +44 7424101981
Email ahlam244@liverpool.ac.uk

Study information

Study designInterventional randomized controlled trial feasibility study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Community
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet.
Scientific titleAdaptation and implementation of health Qigong and Tai Chi exercises on quality of life and physical functioning in patients with atrial fibrillation: a feasibility study
Study objectivesTo assess the feasibility of a future randomised controlled trial of Tai Chi and Qigong for patients with atrial fibrillation in terms of patients’ acceptability and capability to continue the programme and satisfaction with it, in addition to evaluating health-related quality of life and physical functioning.
Ethics approval(s)Approved 04/08/2021, North West - Liverpool Central Research Ethics Committee (Barlow House, 3rd Floor, 4 Minshull Street, Manchester, M1 3DZ, UK; +44 2071048016; liverpoolcentral.rec@hra.nhs.uk), ref: 21/NW/0183
Health condition(s) or problem(s) studiedTai Chi and Qigong for patients with atrial fibrillation.
InterventionCurrent intervention as of 27/12/2023:
Approximately 106 participants will be recruited from primary care. The study took place online via the virtual platform (Zoom). The participants were randomly assigned to either the control (usual care) or intervention group (Tai Chi/Qigong). The exercise group learned a Tai Chi and Qigong routine, led by a qualified instructor. All the movements were carried out according to the participants' capabilities.

The participants in both groups may be interviewed online for process evaluation requirements; and 10 participants from the intervention group for the embedded qualitative study.

Participants in the control group will receive usual care for the management of atrial fibrillation, consisting of stroke prevention (oral anticoagulation), AF-symptom management (rate and/or rhythm control), and management of cardiovascular and other comorbidities, as appropriate.

Participants in the intervention group will practise Qigong and Tai Chi exercises for 60 minutes for up to three sessions per week (one session minimum) for 12 weeks, either in the local community centre or online via Zoom in groups.

Patients will also receive usual care for the management of atrial fibrillation.

_____

Previous intervention:
Approximately 106 participants will be recruited from primary care. The study will take place in the community centres and/or online via the virtual platform (Zoom). The participants will be randomly assigned to either control (usual care) or intervention group (Tai Chi/Qigong). The exercise group, will learn a Tai Chi and Qigong routine, led by a qualified instructor. All the movements will be carried out according to the participants' capability.
The participants in both groups may be interviewed online for process evaluation requirements; and 10 participants from the intervention group for the embedded qualitative study.

Participants in the control group will receive usual care for the management of atrial fibrillation, consisting of stroke prevention (oral anticoagulation), AF-symptom management (rate and/or rhythm control), and management of cardiovascular and other comorbidities, as appropriate.

Participants in the intervention group will practise Qigong and Tai Chi exercises for 60 minutes for up to three sessions per week (one session minimum) for 12 weeks, either in the local community centre or online via Zoom in groups. Patients will also receive usual care for the management of atrial fibrillation.
Intervention typeOther
Primary outcome measureRecruitment rate and retention rate at baseline, during 12 weeks of the intervention:
1. Recruitment rate: the number of the returned consent-to-contact forms will be calculated from the total number of invitations sent to eligible patients (response rate). The total number of those who will attend the intervention will be counted and will be divided by the number of invitations sent.
2. Retention rate: the number of sessions that participants attend over the 12 weeks will be collected and whether they complete the whole session each time or not. 100% attendance will be recorded as a minimum of one session per week for 12 weeks.
Secondary outcome measuresCurrent secondary outcome measures as of 27/12/2023:
1. Health-related quality of life and physical functioning assessed using the Short Form 12-item questionnaire (SF-12), Atrial Fibrillation Effect on Quality-of-life (AFEQT) Questionnaire, and the EuroQol questionnaire (EQ-5D) at baseline, 6 and 12 weeks
2. Patient satisfaction with the intervention was measured using a researcher-developed questionnaire at 12 weeks

_____

Previous secondary outcome measures:
1. Health-related quality of life will be assessed using the Short Form 12-item questionnaire (SF-12), Atrial Fibrillation Effect on Quality-of-life (AFEQT) Questionnaire, and the EuroQol questionnaire (EQ-5D), at baseline, 6 and 12 weeks
2. Physical functioning will be measured by the 6-minute walk test (6MWT), at baseline, 6 and 12 weeks
3. Balance, gait and mobility will be measured by The Short Physical Performance Battery test (SPPB), at baseline, 6 and 12 weeks
4. Patient satisfaction with the intervention will be measured using a researcher-developed questionnaire, at 12 weeks
Overall study start date01/03/2020
Completion date31/12/2023

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants106
Total final enrolment74
Key inclusion criteria1. Confirmed diagnosis of AF.
2. Able to understand spoken English.
3. Able to provide written informed consent.
4. Adults aged ≥18 years old.
5. If social distancing due to COVID-19 persists: the participants should have internet access at home and download free Zoom software onto a computer, mobile phone, or any electronic tablet or TV for delivery of the exercise intervention.
Key exclusion criteria1. Pre-existing medical condition preventing safe exercising (i.e., inability to stand unaided).
Date of first enrolment18/01/2022
Date of final enrolment30/04/2023

Locations

Countries of recruitment

  • England
  • United Kingdom
  • Wales

Study participating centre

Edge Hill Youth and Community Centre
79 Durning Road
Liverpool
L7 5ND
United Kingdom

Sponsor information

University of Liverpool
University/education

4th Floor Thompson Yates Building
Liverpool
L69 3GB
England
United Kingdom

Phone +44 151 794 8373
Email sponsor@liv.ac.uk
Website http://www.liv.ac.uk/
ROR logo "ROR" https://ror.org/04xs57h96

Funders

Funder type

Government

Libyan Embassy - Cultural Attache

No information available

Results and Publications

Intention to publish date31/12/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in non-publicly available repository, Available on request
Publication and dissemination planThe obtained results from this study will be published in scientific journals and reported at scientific conferences and meetings. In addition, all participants will be informed of the study results once published.
IPD sharing planThe data will be held at the University of Liverpool. Requests for de-identified data can be made, along with details on the planned analyses. Data will not be available until 2025. All data will be de-identified. All participants will provide written informed consent.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No
Other unpublished results 13/12/2024 No No

Additional files

ISRCTN16703816_Unpublished Results.pdf

Editorial Notes

13/12/2024: Unpublished results uploaded.
27/12/2023: The following changes have been made:
1. The intervention has been changed.
2. The secondary outcome measures have been changed.
3. East Wavertree and Childwall Community Centre has been removed from the study participating centres.
4. The plain English summary has been updated to reflect these changes.
09/05/2023: The total final enrolment was added.
31/03/2023: The recruitment end date has been changed from 31/01/2023 to 30/04/2023.
28/11/2022: The recruitment end date was changed from 30/11/2022 to 31/01/2023.
03/05/2022: The study contact has been updated and the plain English summary has been updated accordingly.
01/04/2022: added CPMS number to Protocol /serial number field.
25/03/2022: The public title has been changed from "Health Qigong/Tai Chi and irregular heart rhythm" to "Adaptation and implementation of health Qigong and Tai Chi exercises on quality of life and physical functioning in patients with atrial fibrillation: a feasibility study".
01/03/2022: Trial's existence confirmed by North West - Liverpool Central Research Ethics Committee